Meyer Andrew Hollman

CIK 00018641591 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001864159

Recent Transactions

46 trades

Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2026-01-02$13.73/sh−1,879→ 83,095 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2025-12-01−3,333→ 114,768 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2025-12-01$33.52/sh−633→ 84,974 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2025-12-01$32.85/sh−2,700→ 85,607 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2025-12-01$10.59/sh+3,333→ 88,307 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2025-11-14−3,333→ 118,101 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2025-11-14$10.59/sh+3,333→ 88,307 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2025-11-14$30.00/sh−3,333→ 84,974 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2025-10-28$10.59/sh+6,666→ 98,804 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2025-10-28$4.21/sh+9,999→ 92,138 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2025-10-28−6,666→ 121,434 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2025-10-28−9,999→ 77,333 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2025-10-28$30.06/sh−16,665→ 82,139 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2025-05-01$4.21/sh+3,333→ 85,472 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2025-05-01$31.95/sh−2,933→ 82,539 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2025-05-01$32.60/sh−400→ 82,139 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2025-05-01−3,333→ 87,332 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2025-04-21$30.00/sh−3,334→ 82,139 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2025-04-21$4.21/sh+3,334→ 85,473 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2025-04-21−3,334→ 90,665 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2025-03-03$32.85/sh−901→ 82,139 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2025-03-03−3,334→ 93,999 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2025-03-03$31.88/sh−2,433→ 83,040 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2025-03-03$4.21/sh+3,334→ 85,473 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2025-02-03$4.21/sh+3,334→ 85,473 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2025-02-03$42.08/sh−2,418→ 83,055 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2025-02-03$43.60/sh−100→ 82,139 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2025-02-03−3,334→ 97,333 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2025-02-03$42.77/sh−816→ 82,239 total
Award
Janux Therapeutics, Inc.$JANX
Stock option (right to buy)
2025-01-02+63,000→ 63,000 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2025-01-02$53.76/sh−2,922→ 92,551 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2025-01-02$55.76/sh−3,444→ 83,339 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2025-01-02$57.37/sh−200→ 82,139 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2025-01-02$56.78/sh−1,000→ 82,339 total
Award
Janux Therapeutics, Inc.$JANX
Common Stock
2025-01-02+18,000→ 95,473 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2025-01-02$54.51/sh−5,768→ 86,783 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2024-12-19−9,880→ 96,870 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2024-12-19$14.02/sh+1→ 77,473 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2024-12-19−1→ 89,999 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2024-12-19$20.24/sh+9,880→ 77,472 total
Sale
Janux Therapeutics, Inc.$JANX
Common Stock
2024-09-27$45.96/sh−50,000→ 67,592 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2024-09-27−50,000→ 100,667 total
Exercise/Conversion
Janux Therapeutics, Inc.$JANX
Common Stock
2024-09-27$4.21/sh+50,000→ 117,592 total
Award
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2024-01-02+105,000→ 105,000 total
Award
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2023-01-03+90,000→ 90,000 total
Award
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2022-01-03+106,750→ 106,750 total

Companies

Janux Therapeutics, Inc.
Chief Business Officer
$JANX

Recent Filings

Address

C/O JANUX THERAPEUTICS, INC. 10955 VISTA SORRENTO PARKWAY, SUITE 200

SAN DIEGO, CA, 92130

View on SEC.gov